期刊文献+

江西省2009年-2012年B型流感病毒耐药基因分析 被引量:3

Drug resistance analysis of influenza B virus in Jiangxi from 2009 to 2012
原文传递
导出
摘要 目的分析江西省2009年-2012年B型流感病毒耐药基因位点,掌握其耐药情况,为临床治疗和疾病控制提供参考。方法采集监测医院和疑似流感疫情的流感样病例鼻咽拭子标本进行流感病毒分离,随机选择分离到的B型流感病毒进行核酸提取,采用逆转录-聚合酶链反应(RT-PCR)扩增病毒NA基因后进行核苷酸序列测定,用DNAStar5.0,Mage 3.1生物软件对测序结果进行分析处理,推导出氨基酸序列,进行基因特性分析。结果 24株B型流感病毒NA区域核苷酸序列长度均为1 398 bp,编码466个氨基酸,所有毒株的NA蛋白催化活性位点和辅助位点均未发生氨基酸替换。结论 24株毒株均对流感病毒神经氨酸酶抑制剂药物敏感,但仍应加强对流感病毒的耐药性监测。 Objective To understand the molecular characterization of neuraminidase(NA) genes and NA drug resistance of influenza B virus in Jiangxi from 2009 to 2012,so as to provide reference for clinical treatment and diseases control.Methods The nasopharyngeal swabs specimens were collected from influenza-like cases of influenza monitoring hospitals for influenza B virus isolation. Twenty-four strains of influenza B virus were randomly selected for virus RNA extraction. Then fragments of NA genes were amplified by one-step RT-PCR and sequenced. The sequencing results were analyzed with the software DNAStar 5. 0 and Mage 3. 1. Results The NA gene of the 24 influenza B strains was consisted of 1 398 nucleotides,encoding 466 amino acids. All strains were not found mutations in catalytic active sites and associated sites of NA gene. Conclusion The 24 influenza B virus strains were all sensitive to neuraminidase-inhibitor drugs,but continuous drug resistance surveillance is still necessary for control and prevention of influenza.
出处 《中国卫生检验杂志》 北大核心 2014年第15期2232-2234,2259,共4页 Chinese Journal of Health Laboratory Technology
基金 江西省卫生厅科技项目(20112003)
关键词 B型流感病毒 耐药性 NA基因 Influenza B virus Resistance NA gene
  • 相关文献

参考文献17

  • 1郭元古,程小雯.流行性感冒及其实验技术[M].北京:中国三峡出版社,1997:1-43.
  • 2WHO. WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans - revised [ R ]. Geneva: WHO, 2009: 15.
  • 3WHO. WHO information for molecular diagnosis of influenza virus in humans - update[ R]. Geneva: WHO, 2011 : 16.
  • 4熊英,邹明霞,龚甜,方晓艳,施勇.2004~2006年江西省乙型流感病毒HA1基因特性分析[J].中国卫生检验杂志,2008,18(2):211-213. 被引量:16
  • 5Burnham AL, Baranovieh T, Govorkova EA. Neuraminidase inhibi- tors for influenza B virus infection: efficacy and resistance[ J]. Anti- viral Res, 2013, 100(2) : 520 -534.
  • 6Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bac- terial pneumonia contribute to the pathogenesis of fatal influenza B vi- rus infection[J]. J Infect Dis, 2012, 205(6) : 895 -905.
  • 7Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase[ J ]. Nature, 1983, 303(5912) : 41 -44.
  • 8Gubareva LV, Matrosovich MN, Brenner MK, et al. Evidence for zanamivir resistance in an immunocompromised child infeeted with influenza B virus[J]. J Infect Dis, 1998, 178(5) : 1257 -1262.
  • 9Higgins RR, Beniprashad M, Chang - King E, et al. Recovery of influenza B virus with the H273Y point mutation in the neuramini- dase active site from a human patient[ J]. J Clin Microbiol, 2012, 50(7) : 2500 -2502.
  • 10Carr S, Ilyushina NA, Franks J, et al. Oseltamivir - resistant influ- enza A and B viruses pre - and postantiviral therapy in children and young adults with cancer[ J]. Pediatr Infect Dis J, 2011, 30 (4) : 284 -288.

二级参考文献5

共引文献15

同被引文献11

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部